[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=b8ba10b7a882e45ad64f67198e203536761ddff3e2e3d874cd5b9800a69ff4ec",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745944560,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 134149230,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=b8ba10b7a882e45ad64f67198e203536761ddff3e2e3d874cd5b9800a69ff4ec"
    }
  },
  {
    "ts": null,
    "headline": "Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for",
    "summary": "Entrada Therapeutics (TRDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=56786657920fade16afed628038e59f9b0d5e0cb4cc459410b181a9e83387bac",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745935292,
      "headline": "Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for",
      "id": 134131235,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Entrada Therapeutics (TRDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=56786657920fade16afed628038e59f9b0d5e0cb4cc459410b181a9e83387bac"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Gears Up to Report Q1 Earnings: Is a Beat in the Cards?",
    "summary": "On VRTX's first-quarter earnings call, investors are likely to focus on the launch preparation for Alyftrek (vanza triple) and Journavx (suzetrigine).",
    "url": "https://finnhub.io/api/news?id=c9044376d3a44fe9ea96199a476007a4438d0ad92c76fea1678e1dd50943d7c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745927460,
      "headline": "Vertex Gears Up to Report Q1 Earnings: Is a Beat in the Cards?",
      "id": 134131236,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "On VRTX's first-quarter earnings call, investors are likely to focus on the launch preparation for Alyftrek (vanza triple) and Journavx (suzetrigine).",
      "url": "https://finnhub.io/api/news?id=c9044376d3a44fe9ea96199a476007a4438d0ad92c76fea1678e1dd50943d7c5"
    }
  },
  {
    "ts": null,
    "headline": "Baron Health Care Fund Q1 2025 Top Net Purchases And Sales",
    "summary": "Baron Health Care Fund declined 2.54% in Q1 2025. What were the top net purchases and sales? Click here to find out.",
    "url": "https://finnhub.io/api/news?id=846698c72b48a480efd3da2fcda3b03f62d835328919b4d86afee975d065775e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745927100,
      "headline": "Baron Health Care Fund Q1 2025 Top Net Purchases And Sales",
      "id": 134128667,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1156804976/image_1156804976.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Baron Health Care Fund declined 2.54% in Q1 2025. What were the top net purchases and sales? Click here to find out. ",
      "url": "https://finnhub.io/api/news?id=846698c72b48a480efd3da2fcda3b03f62d835328919b4d86afee975d065775e"
    }
  },
  {
    "ts": null,
    "headline": "Baron Health Care Fund Q1 2025 Top Contributors And Detractors",
    "summary": "Baron Health Care Fund declined 2.54% in Q1 2025. Who were the leaders and laggards? Click here to find out.",
    "url": "https://finnhub.io/api/news?id=64360e2ab5d7c801187183c998d5cb1993bbd2f845ff25b1630d3ed1c274fe69",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745926200,
      "headline": "Baron Health Care Fund Q1 2025 Top Contributors And Detractors",
      "id": 134127928,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345347757/image_1345347757.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Baron Health Care Fund declined 2.54% in Q1 2025. Who were the leaders and laggards? Click here to find out. ",
      "url": "https://finnhub.io/api/news?id=64360e2ab5d7c801187183c998d5cb1993bbd2f845ff25b1630d3ed1c274fe69"
    }
  }
]